Magnetic Stem Cells for Gene Engineering
Scientists from the Tomsk Polytechnic University’s Laboratory of Novel Dosage are developing a technology to control mesenchymal stem cells in patients. The technology could improve cancer cell therapy and make it more effective. To fight cancer cells the scientists suggest using the patient’s own cells. Native body cells won’t be rejected by its immune system and can deliver medication directly to the center of the disease.
The development of magnetic cells is jointly carried out by Tomsk polytechnic researchers and colleagues from Pavlov State Medical University of St. Petersburg and Queen Mary University of London.
The novel technology implies that mesenchymal stem cells (MSCs) of the patient’s body with the size about 10 microns are internalized with magnetic controlled microcapsules with a drug inside them. External triggering (magnet) targets cells to tumors; make microcontainers open and releases the encapsulated compound. Thus, the drug is precisely delivered affecting cancer cells and without causing harm to health.
“Mesenchymal stem cells are inherently able to migrate toward tumors. They can also differentiate under control into mesodermal cell types of bone, fat, cartilage, muscle or connective tissue (adipocytes, osteoblasts, chondrocytes, tenocytes, and cells of bone marrow stroma) in vivo and in vitro. Therefore, MSCs are very attractive for researchers and practical physicians to apply them in substitute therapy, gene or cell engineering,” says one of the development’s co-authors Alexander Timin, JRF at the Novel Dosage Laboratory, RASA Center at TPU.
In the study the scientists have demonstrated for the first time the efficiency of internalization of magnetic microcapsules by MSCs to functionalize cells and to design magnetic controlled cells and tissue engineering systems.
“It is interesting to note MSCs exhibit a high ability to internalize (capture) microcapsules without significant toxicity compared to other cell lines described in the literature. As a result of magnetic capsules internalization by MSCs we create a new cell engineering platform which is responsive to external magnetic field to control cell migration. This way magnetization of MSCs enables magnetic sorting of cells and form a cell spheroid out of tens of thousands of MSCs. Also, the obtained results can be further used to create a next generation cell-modified platform for efficient targeted delivery ex vivo,” the authors note.
The scientists have published their results in Advanced Healthcare Materials.
Please note: The content above may have been edited to ensure it is in keeping with Technology Networks’ style and length guidelines.
A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.READ MORE
18th International Conference on Pharmaceutics & Novel Drug Delivery Systems
May 27 - May 28, 2019